» Articles » PMID: 29641997

MYC Releases Early Reprogrammed Human Cells from Proliferation Pause Via Retinoblastoma Protein Inhibition

Overview
Journal Cell Rep
Publisher Cell Press
Date 2018 Apr 12
PMID 29641997
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we report that MYC rescues early human cells undergoing reprogramming from a proliferation pause induced by OCT3/4, SOX2, and KLF4 (OSK). We identified ESRG as a marker of early reprogramming cells that is expressed as early as day 3 after OSK induction. On day 4, ESRG positive (+) cells converted to a TRA-1-60 (+) intermediate state. These early ESRG (+) or TRA-1-60 (+) cells showed a proliferation pause due to increased p16INK4A and p21 and decreased endogenous MYC caused by OSK. Exogenous MYC did not enhance the appearance of initial reprogramming cells but instead reactivated their proliferation and improved reprogramming efficiency. MYC increased expression of LIN41, which potently suppressed p21 post-transcriptionally. MYC suppressed p16 INK4A. These changes inactivated retinoblastoma protein (RB) and reactivated proliferation. The RB-regulated proliferation pause does not occur in immortalized fibroblasts, leading to high reprogramming efficiency even without exogenous MYC.

Citing Articles

[Genetics, epigenetics, and environmental factors in life expectancy-What role does nature-versus-nurture play in aging?].

Bierhoff H Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024; 67(5):521-527.

PMID: 38637469 PMC: 11093831. DOI: 10.1007/s00103-024-03873-x.


Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming.

Cipriano A, Moqri M, Maybury-Lewis S, Rogers-Hammond R, de Jong T, Parker A Nat Aging. 2023; 4(1):14-26.

PMID: 38102454 PMC: 11058000. DOI: 10.1038/s43587-023-00539-2.


is critical to maintain the cell survival and self-renewal/pluripotency of hPSCs by collaborating with MCM2 to suppress p53 pathway.

Li S, Liu H, Liu W, Shi N, Zhao M, Wanggou S Int J Biol Sci. 2023; 19(3):916-935.

PMID: 36778110 PMC: 9909993. DOI: 10.7150/ijbs.79095.


A neural stem cell paradigm of pediatric hydrocephalus.

Duy P, Rakic P, Alper S, Robert S, Kundishora A, Butler W Cereb Cortex. 2022; 33(8):4262-4279.

PMID: 36097331 PMC: 10110448. DOI: 10.1093/cercor/bhac341.


FOXO3 Expression in Macrophages Is Lowered by a High-Fat Diet and Regulates Colonic Inflammation and Tumorigenesis.

Iftikhar R, Penrose H, King A, Kim Y, Ruiz E, Kandil E Metabolites. 2022; 12(3).

PMID: 35323693 PMC: 8949544. DOI: 10.3390/metabo12030250.


References
1.
Sridharan R, Tchieu J, Mason M, Yachechko R, Kuoy E, Horvath S . Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009; 136(2):364-77. PMC: 3273494. DOI: 10.1016/j.cell.2009.01.001. View

2.
Vervoorts J, Luscher-Firzlaff J, Rottmann S, Lilischkis R, Walsemann G, Dohmann K . Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003; 4(5):484-90. PMC: 1319176. DOI: 10.1038/sj.embor.embor821. View

3.
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T . Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2007; 26(1):101-6. DOI: 10.1038/nbt1374. View

4.
Blackwell T, Kretzner L, Blackwood E, Eisenman R, Weintraub H . Sequence-specific DNA binding by the c-Myc protein. Science. 1990; 250(4984):1149-51. DOI: 10.1126/science.2251503. View

5.
Knoepfler P . Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell. 2008; 2(1):18-21. DOI: 10.1016/j.stem.2007.12.004. View